HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feeding probiotic Lactobacillus rhamnosus (MTCC 5897) fermented milk to suckling mothers alleviates ovalbumin-induced allergic sensitisation in mice offspring.

Abstract
The neonatal period is often polarised to T helper (Th2) response at the time of birth, predisposing offspring to allergic disorders. Passive immunity through the mother's milk is critical for immune system development of newborns. Probiotics have been proposed to harmonise Th1/Th2 imbalance in allergic conditions in adults. In the present study, the anti-allergic effects of feeding probiotic Lactobacillus rhamnosus-fermented milk (PFM) either to dams during the suckling period or to their offspring after weaning individually or else in successive periods against ovalbumin (OVA)-induced allergy in newborns was analysed. After allergen sensitisation, physical symptoms of allergy, gut immune response, humoral immune response and cell-mediated response through interleukins were detected. Consumption of PFM by mothers and offspring showed a reduction (P<0·01) in physical allergic symptoms in newborns with an increase (P<0·01) in the numbers of goblet and IgA+ cells in the small intestine. Similarly, considerable (P<0·001) decreases in OVA-specific antibodies (IgE, IgG, IgG1) and ratios of IgE/IgG2a and IgG1/IgG2a in the sera of newborn mice were recorded. A decrease in IL-4 and an increase in interferon-γ levels further confirmed the shift from Th2 to Th1 pathway in PFM-fed mice. It is logical to conclude that the timing of PFM intervention in alleviating allergic symptoms is critical, which was found to be most effective when mothers were fed during the suckling period.
AuthorsVamshi Saliganti, Rajeev Kapila, Rohit Sharma, Suman Kapila
JournalThe British journal of nutrition (Br J Nutr) Vol. 114 Issue 8 Pg. 1168-79 (Oct 28 2015) ISSN: 1475-2662 [Electronic] England
PMID26330132 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Allergens
  • Anti-Allergic Agents
  • Ccl2 protein, mouse
  • Chemokine CCL2
  • Immunoglobulin G
  • Tlr2 protein, mouse
  • Tlr4 protein, mouse
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
  • Transforming Growth Factor beta
  • Interleukin-10
  • Interleukin-4
  • Immunoglobulin E
  • Interferon-gamma
  • Ovalbumin
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
Topics
  • Allergens (administration & dosage)
  • Animals
  • Anti-Allergic Agents (administration & dosage)
  • Chemokine CCL2 (genetics, metabolism)
  • Cyclooxygenase 2 (genetics, metabolism)
  • Female
  • Fermentation
  • Food Hypersensitivity (prevention & control)
  • Immunoglobulin E (blood, immunology)
  • Immunoglobulin G (blood, immunology)
  • Interferon-gamma (blood, immunology)
  • Interleukin-10 (blood, immunology)
  • Interleukin-4 (blood, immunology)
  • Intestines (immunology, microbiology)
  • Lacticaseibacillus rhamnosus
  • Male
  • Mice
  • Milk (chemistry)
  • Ovalbumin (blood, immunology)
  • Probiotics (administration & dosage)
  • Th1 Cells (metabolism)
  • Th2 Cells (metabolism)
  • Toll-Like Receptor 2 (genetics, metabolism)
  • Toll-Like Receptor 4 (genetics, metabolism)
  • Transforming Growth Factor beta (blood, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: